{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:52:29Z","timestamp":1778813549890,"version":"3.51.4"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,6,19]],"date-time":"2002-06-19T00:00:00Z","timestamp":1024444800000},"content-version":"vor","delay-in-days":49,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p> <jats:bold>BACKGROUND<\/jats:bold>: Severe deficiency of vWF\u2010cleaving protease (vWF\u2010CPase) activity was recently found in patients with thrombotic thrombocytopenic purpura (TTP). Although the survival of patients with TTP has been dramatically improved with plasma exchange (PE), there are still many patients who are refractory to PE and immunosuppressive therapy.<\/jats:p><jats:p> <jats:bold>STUDY DESIGN AND METHODS<\/jats:bold>: The activities of vWF\u2010CPase and its inhibitor were measured in 27 patients with nonfamilial TTP and hemolytic\u2010uremic syndrome (HUS) to examine the relationship between the clinical variables and vWF\u2010CPase activity.<\/jats:p><jats:p> <jats:bold>RESULTS<\/jats:bold>: Eight of nine patients with HUS had more than 40 percent of vWF\u2010CPase activity, whereas one had 28 percent of the normal level at the acute phase. Ten of 12 TTP patients with a good outcome had a severe deficiency of vWF\u2010CPase activity and its inhibitor, whereas four of six patients with a poor outcome had a moderate deficiency of vWF\u2010CPase activity along with a lack of the inhibitor. PE produced normalization of the vWF\u2010CPase activity and neutralization of the inhibitor in TTP patients with a good outcome; however, some TTP patients with vWF\u2010CPase inhibitor had relapsed and required an immunosuppressive therapy. The response to the combination therapy with PE and immunosuppressive treatment was poor in TTP patients without a severe deficiency of vWF\u2010CPase activity.<\/jats:p><jats:p> <jats:bold>CONCLUSION<\/jats:bold>: Assays of vWF\u2010CPase activity and its inhibitor may be useful for predicting the response to therapy and the outcome of patients with TTP. In some patients, nonfamilial TTP with a poor prognosis may not be caused by a constitutional or acquired deficiency of vWF\u2010CPase with its inhibitor. Although PE and immunosuppressive therapy are effective in patients with nonfamilial TTP and a vWF\u2010CPase inhibitor, other therapeutic modalities may be needed for nonfamilial TTP with unknown etiology.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2002.00100.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:50:10Z","timestamp":1047509410000},"page":"572-580","source":"Crossref","is-referenced-by-count":100,"title":["Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF\u2010cleaving protease\u2003activity"],"prefix":"10.1111","volume":"42","author":[{"given":"Yoshitaka","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban C.","family":"Gabazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nobori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Shiku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ishizashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,6,19]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"287","article-title":"Thrombotic thrombocytopenic purpura: a review.","volume":"6","author":"Bukowski RM","year":"1982","journal-title":"Rev Prog Hemost Thromb"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196603000-00003"},{"key":"e_1_2_6_4_2","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease.","volume":"24","author":"Moschcowitz E","year":"1924","journal-title":"Proc N Y Pathol Society"},{"key":"e_1_2_6_5_2","first-page":"905","article-title":"Hemolytic uremic syndrome: bilateral renal necrosis in acute acquired anemia.","volume":"85","author":"Gasser C","year":"1955","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197909000-00004"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861001)58:7<1428::AID-CNCR2820580709>3.0.CO;2-J"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212023072306"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.","volume":"87","author":"Furlan M","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.","volume":"87","author":"Tsai H\u2010M","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor\u2010cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.","volume":"89","author":"Furlan M","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392203"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982558"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03222.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981975"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1654"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1662"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100515200"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1055\/s-0037-1614778","article-title":"Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?","volume":"82","author":"Mannucci PM","year":"1999","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199807)58:3<189::aid-ajh5>3.0.co;2-n"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602969900500206"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90753-4"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","article-title":"von Willebrand factor: a reduced and alkylated 52\/48\u2010kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib.","volume":"261","author":"Fujimura Y","year":"1986","journal-title":"J Biol Chem"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109795"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1645215"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614408"},{"key":"e_1_2_6_29_2","first-page":"612","article-title":"Proceedings: a more uniform measurement of factor VIII inhibitors.","volume":"34","author":"Kasper CK","year":"1975","journal-title":"Thrombosis Diath Haemorrh"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood.V64.3.592.592","article-title":"Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic\u2010uremic syndrome.","volume":"64","author":"Moake JL","year":"1984","journal-title":"Blood"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420306"},{"key":"e_1_2_6_32_2","first-page":"H1635","article-title":"Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells.","volume":"256","author":"Frangos JA","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V65.5.1232.1232","article-title":"Effects of fresh\u2010frozen plasma and its cryosupernatant fraction on von Wille\u2010 brand factor multimeric forms in chronic relapsing thrombosis thrombocytopenic purpura.","volume":"65","author":"Moake JL","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_34_2","first-page":"1199","article-title":"Plasma von Willebrand factor processing activity functions like a disulfide bond reductase: reversible decrease of multimer size (abstract).","volume":"69","author":"Phillips MD","year":"1993","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_35_2","first-page":"83","article-title":"Studies on the pathophysiology of thrombotic thrombocytopenic purpura.","volume":"34","author":"Moake JL","year":"1997","journal-title":"Semin Hematol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108083250604"},{"key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor\u2010cleaving protease in a patient with thrombotic thrombocytopenic purpura.","volume":"91","author":"Furlan M","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0037-1614062","article-title":"Thrombotic thrombocytopenic purpura: a paradigm shift?","volume":"84","author":"Cines DB","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_39_2","first-page":"247","article-title":"Bone marrow transplant\u2010associated thrombotic microangiopathy: a case series.","volume":"15","author":"Zeigler ZR","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow\u2010associated thrombotic thrombocytopenic purpura.","volume":"93","author":"Van der Plas RM","year":"1999","journal-title":"Blood"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2002.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2002.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:44:50Z","timestamp":1697237090000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2002.00100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1046\/j.1537-2995.2002.00100.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2002.00100.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}